A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Henan Cancer Hospital
Institut Paoli-Calmettes
Centre Hospitalier Universitaire Vaudois
Zhejiang University
Aurigene Discovery Technologies Limited
Massachusetts General Hospital
Kineta Inc.
Fox Chase Cancer Center
The First Affiliated Hospital of Soochow University
Wuhan Ammunition Life-tech Co., Ltd
Revolution Medicines, Inc.
University of Maryland, Baltimore
ChineseAMS
SpeciCare
MultiVir, Inc.
Samyang Biopharmaceuticals Corporation
Shenzhen BinDeBio Ltd.
Instituto do Cancer do Estado de São Paulo
University of Erlangen-Nürnberg Medical School
Ottawa Hospital Research Institute
Shenzhen Second People's Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)